A seven-compound nutraceutical protocol (Omega-3 EPA ≥60%, Saffron 30mg, SAM-e, L-Methylfolate, Zinc, Curcumin+piperine, Magnesium glycinate) has demonstrated adjunctive efficacy for anxiety and depression across multiple RCTs and meta-analyses. Omega-3 EPA (≥1g/day) reduces depressive symptoms with effect size d≈0.61 in meta-analysis; Saffron 30mg/day matches fluoxetine 20mg in multiple head-to-head RCTs (n=40–60 per study). SAM-e (800–1600mg) and L-Methylfolate (15mg) show strong evidence specifically as SSRI augmentation. This protocol is intended as an adjunct to, not replacement for, standard psychiatric care.
22 sources 4/4 strong Updated 2026-04-15
The gut-brain axis is a real, bidirectional communication system — but the psychobiotic field suffers from a critical strain-specificity problem: evidence for one strain cannot be extrapolated to another, even within the same species. The strongest human RCT evidence comes from L. rhamnosus HN001 (perinatal mood, OR 0.44), B. longum NCC3001 (IBS-related depression with fMRI confirmation), and multi-strain combinations. Omega-3 and inositol provide complementary mechanisms. This protocol layers interventions by evidence strength across 3 phases, with dietary change as the non-negotiable foundation.
7 sources 3/4 moderate Updated 2026-04-15